SAN DIEGO, April 2, 2018 /PRNewswire/ -- NuVasive, Inc.
(NASDAQ: NUVA), the leader in spine technology innovation, focused
on transforming spine surgery with minimally disruptive,
procedurally integrated solutions, today announced the launch of
ALIF (Anterior Lumbar Interbody Fusion) Access, the Company's
first-ever MAS® (Maximum Access Surgery) ALIF retractor platform
for both lateral and supine spine surgery approaches.
The retractor system's features help retain the characteristics
of a traditional ALIF while giving surgeons options for either a
lateral or supine approach based on patient need.
For lateral entry, the Lateral ALIF Access System enables
single-position surgery for multilevel cases when integrated with
the NuVasive XLIF® procedure, increasing O.R. efficiency by
reducing the number of times a patient has to be repositioned and
expanding the benefits of lateral surgery to more spinal
levels.
"Accessing L5/S1 laterally has historically had its
shortcomings, specifically because the existing systems on the
market were not designed from the ground up for these approaches,"
said Dr. J. Alex Thomas MD. "Access
systems used in the past were lacking in various clinically
necessary areas. NuVasive has addressed these clinical concerns
with their new ALIF Access platform, whether it is a traditional
supine approach or as the surgeon moves towards single-position
surgery, they've created a real game changer for ALIF
approaches."
For the exposure surgeon, the NuVasive ALIF Access platform
supports the traditional supine ALIF approach with features to
enhance imaging and direct visualization of the spine and goes a
step further by offering new opportunities for access from the
lateral decubitus position. The learning curve for accessing L5/S1
from the lateral position mimics that of a supine approach,
minimizing adoption hurdles for access surgeons. NuVasive has
streamlined access for both approaches by creating a flexible
platform which fluently translates between the surgeon's desired
approach, based on patient anatomy and pathology.
"ALIF Access exemplifies our commitment to innovation and
providing relevant solutions to meet the diverse and evolving needs
of our surgeons," said Matt Link,
executive vice president, strategy, technology and corporate
development for NuVasive. "XLIF is the foundation on which NuVasive
is built, and the Lateral ALIF Access System empowers the surgeon
to take XLIF to another level by incorporating a single-position
protocol for a better all-around surgeon and patient experience.
NuVasive remains laser-focused on delivering game-changing,
procedural solutions and systems to market with the tools and
training required to create the best clinical outcomes for the
patient."
Regardless of the approach, either lateral or supine, ALIF
Access is fully compatible with the NuVasive anterior implant
portfolio and comprises a carbon fiber frame for strength and
radiolucency as well as customizable retractor blade size and
positioning for optimum flexibility.
About NuVasive
NuVasive, Inc. (NASDAQ:
NUVA) is the leader in spine technology innovation, focused on
transforming spine surgery and beyond with minimally disruptive,
procedurally-integrated solutions designed to deliver reproducible
and clinically-proven surgical outcomes. The Company's portfolio
includes access instruments, implantable hardware, biologics,
software systems for surgical planning, navigation and imaging
solutions, magnetically adjustable implant systems for spine and
orthopedics, and intraoperative monitoring service offerings. With
over $1 billion in revenues, NuVasive
has an approximate 2,400 person workforce in more than 40 countries
serving surgeons, hospitals and patients. For more information,
please visit www.nuvasive.com.
Forward-Looking Statements
NuVasive cautions
you that statements included in this news release that are not a
description of historical facts are forward-looking statements that
involve risks, uncertainties, assumptions and other factors which,
if they do not materialize or prove correct, could cause NuVasive's
results to differ materially from historical results or those
expressed or implied by such forward-looking statements. The
potential risks and uncertainties which contribute to the uncertain
nature of these statements include, among others, risks associated
with acceptance of the Company's surgical products and procedures
by spine surgeons, development and acceptance of new products or
product enhancements, clinical and statistical verification of the
benefits achieved via the use of NuVasive's products (including the
iGA® platform), the Company's ability to effectually manage
inventory as it continues to release new products, its ability to
recruit and retain management and key personnel, and the other
risks and uncertainties described in NuVasive's news releases and
periodic filings with the Securities and Exchange Commission.
NuVasive's public filings with the Securities and Exchange
Commission are available at www.sec.gov. NuVasive assumes no
obligation to update any forward-looking statement to reflect
events or circumstances arising after the date on which it was
made.
View original content with
multimedia:http://www.prnewswire.com/news-releases/nuvasive-portfolio-now-includes-alif-retractor-platform-for-lateral-and-supine-approaches-300621934.html
SOURCE NuVasive, Inc.